Sumatriptan/Promethazine

舒马普坦/异丙嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSumatriptan/Promethazine
Drug Alias Name舒马普坦和异丙嗪Promethazine/Sumatriptan异丙嗪/舒马普坦Sumatriptan-Promethazine mixtSumatriptan and Promethazine +[12] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsSerotonin (5-HT) receptor agonists
TargetsHistamine H1 receptorSerotonin (5-HT) receptor
Therapy Area/IndicationsNauseaMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Promethazine HydrochlorideSumatriptan Succinate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCharleston Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesCharleston Laboratories Inc
Inactive CompaniesN/A
Active IndicationsNauseaMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A